Summit Therapeutics, Inc. (SMMT)
17.47
-0.42
(-2.35%)
USD |
NASDAQ |
May 21, 16:00
16.73
-0.74
(-4.24%)
After-Hours: 04:51
Summit Therapeutics Research and Development Expense (TTM) : 619.03M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Revolution Medicines, Inc. | 1.117B |
| BioMarin Pharmaceutical, Inc. | 721.03M |
| Relay Therapeutics, Inc. | 258.14M |
| Alnylam Pharmaceuticals, Inc. | 1.420B |
| Amgen, Inc. | 7.514B |